Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 13. March 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8839  Previews Next
   
   Articles 1 - 20 / 176769  
   
Kidney-Sparing Approaches in Upper Tract Urothelial Cancer: A Narrative Review.
Cureus
Kefalas C, Datseris N, Sitaridis K, Mourtzilas E, Papalakis A.
PMID: 41822654 [PubMed]


Application of carbonic anhydrase IX-targeted radiopharmaceuticals in the diagnosis and treatment of clear cell renal cell carcinoma (Review).
Oncol Lett
Wang M, Li Y, Yang W, Liu B.
PMID: 41822559 [PubMed]


Deep learning-based detection and segmentation of osseous metastatic prostate cancer lesions on computed tomography.
Eur J Radiol Artif Intell
Pawan SJ, Rich JM, Malewar S, Patel D, Muellner M, Hwang D, Lei X, Cen S, Triche T, Goldkorn A, Mohamed P, Oberai A, Duddalwar V.
PMID: 41822381 [PubMed]


Functional and Survival Outcomes of Partial Versus Radical Nephrectomy in Renal Cell Carcinoma Patients With Pre-Existing Chronic Kidney Disease: A Real-World Study.
World J Oncol
Thai LK, Luu VQ, Thai SM.
PMID: 41822317 [PubMed]


Muscle size and muscle fat infiltration in patients with newly diagnosed prostate cancer: a case-control study.
Front Oncol
Wang C, Wang H, Yu Y, Yang X, Wang Y, Zhang K, Sun S, Wu L, Fang D, Li H, Yang Y, Chen X, Bi S, Wen H.
PMID: 41821899 [PubMed]


Body mass index and prostate cancer incidence: a comprehensive systematic review.
Front Oncol
Myers D, Chissum Lagos D, Zapata I, Hwang C.
PMID: 41821886 [PubMed]


The prognostic impact of systemic inflammation and nutritional indicators on targeted therapy for renal cell carcinoma: a systematic review and meta-analysis.
Front Nutr
Xiao Y, Dai Y, Zhong X, Zhang L, Xie R, Zhou Q, Liang W, Sun X, Yang M, Zou Z, Wang Y, Li H, Niu T.
PMID: 41821864 [PubMed]


Disulfidptosis and androgenic cancers: from molecular mechanisms to clinical applications and future translational research.
Front Endocrinol (Lausanne)
Wang X, Zhao J, Li Q, Chang J, Zhao W, Xing X.
PMID: 41821736 [PubMed - indexed for MEDLINE]


Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma.
Ann Med
He DL, Zhu FF, Wang J, Zhu SW, Hou SS.
PMID: 41821478 [PubMed - indexed for MEDLINE]


Comparison between artificial intelligence-based and manual organ delineations in pretreatment computed tomography scans of prostate cancer patients: a visual grading study.
Radiat Prot Dosimetry
Polymeri E, Johnsson ÅA, Enqvist O, Ulén J, Kindblom J, Braide K, Wiltz HJ, Tanyasiová M, Trägårdh E, Edenbrandt L, Kjölhede H, Svalkvist A.
PMID: 41821468 [PubMed - indexed for MEDLINE]


Does Insulin Resistance Predict Lower Urinary Tract Symptoms? Results From the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial.
Prostate
Zheng R, Daniels JP, Mirocha JM, Hernández-Tirado A, Moreira DM, Fowke JH, Freedland SJ.
PMID: 41821360 [PubMed - as supplied by publisher]


Conditional Relative Survival and Competing Mortality in Surgically Treated Patients with Localized and Regional Kidney Cancer in Korea: A Nationwide Cohort Study.
Cancer Res Treat
Shin HB, Shin DW, Cho IY, Park J, Hyung JJ, Han K, Park J.
PMID: 41821141 [PubMed - as supplied by publisher]


Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study.
Cancer Med
Cortes-Mejia N, Wong R, Eltzschig HK, Moreno-Lopez SM, Bejarano-Ramirez D, Huang H, Cata JP.
PMID: 41820815 [PubMed - indexed for MEDLINE]


Foundation Model and Multi-Instance Learning-Based Framework for Predicting Lymphovascular Invasion in Prostate Cancer.
Ann Surg Oncol
Zheng Q, Mei H, Wang D, Liu X, Wang L, Chen Z.
PMID: 41820759 [PubMed - as supplied by publisher]


An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer.
Eur Urol Oncol
Grochot R, Guo C, Carreira S, Crespo M, Welti J, Miranda S, Figueiredo I, Bertan C, Rekowski J, Yuan W, Tunariu N, Abramowicz K, Ferreira A, Riisnaes R, Neeb A, Gurel B, Fenor de la Maza MLD, Chandran K, Carmichael J, Westaby D, Kohlhof H, Sharp A, Paschalis A, de Bono J.
PMID: 41820163 [PubMed - as supplied by publisher]


Intraductal histiocytes as a simulant of intraductal carcinoma of the prostate.
Am J Clin Pathol
Wobker SE, Williamson SR, Kenigsberg A, Muthusamy S, Smith SC.
PMID: 41819611 [PubMed - indexed for MEDLINE]


Patient-reported psychological and prostate cancer-specific functional outcomes among men with low-risk prostate cancer two years after diagnosis: The PREPARE prospective cohort study.
Urology
Davis KM, Luta G, Hoffman RM, Lobo T, Zotou V, Potosky AL, Sanda MG, Penson D, Khosrow-Khavar F, Ergas IJ, Van Den Eeden SK, Taylor KL.
PMID: 41819414 [PubMed - as supplied by publisher]


New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study.
Lancet Oncol
Karpinski MJ, Civan C, Rauscher I, Güven O, Eiber M, Hoberück S, Miederer M, Bundschuh RA, Hölscher T, Calais J, Theus L, Nguyen AT, Scholtissek H, Lapa C, Di Giorgio A, Farolfi A, Ufton D, Drzezga A, Kunikowska J, Pe, Evangelista L, Bauman G, Alç, Beintner-Skawran S, Rohani MFM, Miksch J, Hüsing A, Kesch C, Herrmann K, Stuschke M, Umutlu L, Gafita A, Hofman MS, Hope TA, Goffin K, Kind F, Pizzuto DA, Soeterik TFW, Kömek H, Emmett L, Vondrak A, Pinter T, Lanfranchi F, Bauckneht M, Unterrainer LM, Holzgreve A, Bjartell A, Trägårdh E, Rasul S, Miszczyk M, Bögemann M, Rodriguez SantAnna Jauregui N, Schäfers M, Rahbar K, Hadaschik BA, Fendler WP, PROMISE Registry Group.
PMID: 41819113 [PubMed - as supplied by publisher]


Key signaling pathways in the development and progression of prostate cancer: The crosstalk between inflammation, autophagy, and pyroptosis.
Tissue Cell
Cai Y, Liu JB, Chen Y, Yang YM.
PMID: 41819045 [PubMed - as supplied by publisher]


Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
J Assoc Physicians India
Narayanan J, Sundar VE, Mathi SA.
PMID: 41818095 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 176769    Page 1 of 8839  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1